Search

Home > OIS Podcast > Opthea Exploring Different Approach To Treating Wet AMD
Podcast: OIS Podcast
Episode:

Opthea Exploring Different Approach To Treating Wet AMD
Category: Business
Duration: 00:20:23
Publish Date: 2015-08-30 23:00:00
Description: Australia-based Opthea is moving forward with clinical trials in the US, testing its OPT-302 compound along and in combination with Lucentis as a potential treatment for Wet AMD. CEO Megan Baldwin explains the company’s approach up until now and its plans going forward.
Total Play: 0